The JAK2 46/1 haplotype: a marker of inappropriate myelomonocytic response to cytokine stimulation, leading to increased risk of inflammation, myeloid neoplasm, and impaired defense against infection?

被引：54

作者：

Hermouet, Sylvie ^{[1
,2
]}

Vilaine, Mathias ^{[1
]}

机构：

[1] Univ Nantes, INSERM, UMR 892, Inst Rech Therapeut, Nantes, France

[2] CHU Nantes, Hematol Lab, F-44035 Nantes 01, France

来源：

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2011年 / 96卷 / 11期

关键词：

MYELOPROLIFERATIVE NEOPLASMS; POLYCYTHEMIA-VERA; CROHNS-DISEASE; GROWTH-FACTOR; SUSCEPTIBILITY; INTERLEUKIN-11; THROMBOSIS;

D O I：

10.3324/haematol.2011.055392

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1575 / 1579

页数：6

共 21 条

[1] JAK2 46/1 haplotype analysis in myeloproliferative neoplasms and acute myeloid leukemia [J].

Andrikovics, H. ;

Nahajevszky, S. ;

Koszarska, M. ;

Meggyesi, N. ;

Bors, A. ;

Halm, G. ;

Lueff, S. ;

Lovas, N. ;

Matrai, Z. ;

Csomor, J. ;

Rasonyi, R. ;

Egyed, M. ;

Varkonyi, J. ;

Mikala, G. ;

Sipos, A. ;

Kozma, A. ;

Adam, E. ;

Fekete, S. ;

Masszi, T. ;

Tordai, A. .

LEUKEMIA, 2010, 24 (10) :1809-1813

[2] Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: different role of C-reactive protein and pentraxin 3 [J].

Barbui, Tiziano ;

Carobbio, Alessandra ;

Finazzi, Guido ;

Vannucchi, Alessandro M. ;

Barosi, Giovanni ;

Antonioli, Elisabetta ;

Guglielmelli, Paola ;

Pancrazzi, Alessandro ;

Salmoiraghi, Silvia ;

Zilio, Pio ;

Ottomano, Cosimo ;

Marchioli, Roberto ;

Cuccovillo, Ivan ;

Bottazzi, Barbara ;

Mantovani, Alberto ;

Rambaldi, Alessandro .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (02) :315-318

[3] Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease [J].

Barrett, Jeffrey C. ;

Hansoul, Sarah ;

Nicolae, Dan L. ;

Cho, Judy H. ;

Duerr, Richard H. ;

Rioux, John D. ;

Brant, Steven R. ;

Silverberg, Mark S. ;

Taylor, Kent D. ;

Barmada, M. Michael ;

Bitton, Alain ;

Dassopoulos, Themistocles ;

Datta, Lisa Wu ;

Green, Todd ;

Griffiths, Anne M. ;

Kistner, Emily O. ;

Murtha, Michael T. ;

Regueiro, Miguel D. ;

Rotter, Jerome I. ;

Schumm, L. Philip ;

Steinhart, A. Hillary ;

Targan, Stephan R. ;

Xavier, Ramnik J. ;

Libioulle, Cecile ;

Sandor, Cynthia ;

Lathrop, Mark ;

Belaiche, Jacques ;

Dewit, Olivier ;

Gut, Ivo ;

Heath, Simon ;

Laukens, Debby ;

Mni, Myriam ;

Rutgeerts, Paul ;

Van Gossum, Andre ;

Zelenika, Diana ;

Franchimont, Denis ;

Hugot, Jean-Pierre ;

de Vos, Martine ;

Vermeire, Severine ;

Louis, Edouard ;

Cardon, Lon R. ;

Anderson, Carl A. ;

Drummond, Hazel ;

Nimmo, Elaine ;

Ahmad, Tariq ;

Prescott, Natalie J. ;

Onnie, Clive M. ;

Fisher, Sheila A. ;

Marchini, Jonathan ;

Ghori, Jilur .

NATURE GENETICS, 2008, 40 (08) :955-962

[4] Anti-inflammatory cytokines hepatocyte growth factor and interleukin-11 are over-expressed in Polycythemia vera and contribute to the growth of clonal erythroblasts independently of JAK2V617F [J].

Boissinot, M. ;

Cleyrat, C. ;

Vilaine, M. ;

Jacques, Y. ;

Corre, I. ;

Hermouet, S. .

ONCOGENE, 2011, 30 (08) :990-1001

[5] Expression of early placenta insulin-like growth factor in breast cancer cells provides an autocrine loop that predominantly enhances invasiveness and motility [J].

Brandt, B ;

Kemming, D ;

Packeisen, J ;

Simon, R ;

Helms, M ;

Feldmann, U ;

Matuschek, A ;

Kersting, C ;

Hinrichs, B ;

Bidart, JM ;

Bellet, D ;

Bartkowiak, K ;

Dankbar, N ;

Dittmar, T ;

Sauter, G ;

Boecker, W ;

Buerger, H .

[6] JAK2 mutation and disease phenotype: a double L611V/V617F in cis mutation of JAK2 is associated with isolated erythrocytosis and increased activation of AKT and ERK1/2 rather than STAT5 [J].

Cleyrat, C. ;

Jelinek, J. ;

Girodon, F. ;

Boissinot, M. ;

Ponge, T. ;

Harousseau, J-L ;

Issa, J-P ;

Hermouet, S. .

LEUKEMIA, 2010, 24 (05) :1069-1073

[7] Erythropoietin-independent erythroid colony formation by bone marrow progenitors exposed to interleukin-11 and interleukin-8 [J].

Corre-Buscail, I ;

Pineau, D ;

Boissinot, M ;

Hermouet, S .

EXPERIMENTAL HEMATOLOGY, 2005, 33 (11) :1299-1308

[8] Genetic factors in chronic inflammation: Single nucleotide polymorphisms in the STAT-JAK pathway, susceptibility to DNA damage and Crohn's disease in a New Zealand population [J].

Ferguson, Lynnette R. ;

Han, Dug Yeo ;

Fraser, Alan G. ;

Huebner, Claudia ;

Lam, Wen Jiun ;

Morgan, Angharad R. ;

Duan, He ;

Karunasinghe, Nishi .

MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2010, 690 (1-2) :108-115

[9] The JAK2 46/1 haplotype predisposes to MPL-mutated myeloproliferative neoplasms [J].

Jones, Amy V. ;

Campbell, Peter J. ;

Beer, Philip A. ;

Schnittger, Susanne ;

Vannucchi, Alessandro M. ;

Zoi, Katerina ;

Percy, Melanie J. ;

McMullin, Mary Frances ;

Scott, Linda M. ;

Tapper, William ;

Silver, Richard T. ;

Oscier, David ;

Harrison, Claire N. ;

Grallert, Harald ;

Kisialiou, Aliaksei ;

Strike, Paul ;

Chase, Andrew J. ;

Green, Anthony R. ;

Cross, Nicholas C. P. .

BLOOD, 2010, 115 (22) :4517-4523

[10] JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms [J].

Jones, Amy V. ;

Chase, Andrew ;

Silver, Richard T. ;

Oscier, David ;

Zoi, Katerina ;

Wang, Y. Lynn ;

Cario, Holger ;

Pahl, Heike L. ;

Collins, Andrew ;

Reiter, Andreas ;

Grand, Francis ;

Cross, Nicholas C. P. .

NATURE GENETICS, 2009, 41 (04) :446-449

← 1 2 3 →